Researchers at the UConn Center on Aging have uncovered causal links between depression and Alzheimer’s disease and related ...

Eisai and Biogen's Alzheimer's drug Leqembi continued to slow progress of the disease with no new safety issues four years ...

Dr. Ausim Azizi is among those seeing the overall early results, as Yale New Haven Hospital is in the forefront of research ...

Eli Lilly and Company (NYSE: LLY) announced results from the long-term extension (LTE) of the Phase 3 TRAILBLAZER-ALZ 2 study ...

Let’s keep it simple: If you want to delay Alzheimer’s onset, focus on walking and adding nutritious foods, such as walnuts, ...

Long-term data presented at the Alzheimer’s Association International Conference show Leqembi can help patients stay in the ...

The Alzheimer’s Association has issued its first clinical practice guideline on the use of blood tests to help diagnose ...

TORONTO -- Blood tests for Alzheimer's disease biomarkers can be used clinically -- and can replace expensive brain scans and ...

Cognito’s OVERTURE trial demonstrated significant ‘time saved’ in functional and cognitive decline at both six and 18 months.

Alzheimer’s disease, a neurological disorder that affects memory and cognition, has often been portrayed in global cinema. In Hindi cinema, filmmakers have also taken up the challenge of sensitively ...

New tests and new treatments are presenting more options for certain patients with Alzheimer's disease. “Today a confluence ...

JUST off the press this May 2025 is a revolutionary book on Alzheimer’s disease called "Alzheimer’s: Prevention Is the Cure." ...